• AIM: To investigate the mechanism of pericyte migration through Angiopoietin-2 (Ang-2)/Tie-2 signaling pathway.
INTRODUCTION

P
ericyte is vascular mural cell, embedded in membrane base and makes direct contact with endothelial. The highest pericyte coverage is observed in the retinal vasculature, which the ratio to endothelial is 1:1. The higher ratio of pericyte: endothelial, the more important function at the organ. It has been associated with vascular stabilization, like controlling blood flow, capillary permeability, and endothelial regulation [1] [2] [3] [4] [5] . Pericyte will lost in hyperglycemia condition.
It is due to alteration of biochemical pathway, and growth factors. Because the retinal vascular appears to be the most sensitive site for pericyte loss, so the role of the pericyte in early diabetic retinopathy is very important. Pericyte loss is the earliest morphological changes in the diabetic retina which will further affect instability of retinal vasculature. Few researcher have focused on the mechanism of pericyte loss, which is pericyte migration, but the mechanism is still unknown [6] [7] . Angiopoietin-2 (Ang-2) is growth factor that increases in several conditions, like hyperglicemia. Angiopoietin regulates two pathways that mediated cellular motility through its receptor, Tie-2, with activate phosphotidylinositol 3 kinase (PI3K) and through mitogen-activated protein kinase (MAPK) pathways. The role of Ang-2 in Tie-2 phosphorylation is complicated that depends on the stimuli and the cells [8] [9] [10] . The exact role of Ang-2 induced Tie-2 phosphorylation in pericyte and the mechanism of pericyte migration due to hyperglicemia still poorly understood. The aim of this study is to investigate the molecular mechanism of pericyte migration in hyperglicemic retina observed from Ang-2/Tie-2 phosphorylation, Akt/PKB phosphorylation, and ERK1/2 phosphorylation in vivo.
MATERIALS AND METHODS
All experiments in this study were performed with approval from Ethics Committee Medical Faculty Brawijaya University. Animal were housed in groups in cages with standard food and water under 12h light and 12h dark rhythm. Rats were divided into 5 groups. Group 1 was normoglycemic rats (negative control), Group 2-5 were diabetic rats groups. Group 2 was group with DMSO intravitreal injection (positive control), Group 3 was group with Tie-2 inhibitor injection, Group 4 was inhibited with ERK1/2 intravitreal injection, and the last was Akt/PKB inhibition. Ang-2 serum was taken from each group before sacrificed. Induction of Diabetes Mellitus Streptozotocin (STZ) was given 40 mg/kg·d for 5d for inducing diabetic rats. STZ injections were given intraperitoneally and the doses were determined according to the body weight of animals. The blood glucose concentration was measured every week from the day of STZ injection. STZ-injected animals were considered diabetic when blood glucose levels reached stable levels (>250 mg/dL). Diabetic and nondiabetic rats were sacrificed 5wk afterdiabetes induction, and eyes were enucleated under deep anesthesia and immediately frozen and fixed with 10% formalin. Retinal Digest Preparation Retinal digest preparation of each groups were performed using trypsin 3% and done for three days in order to make separation of retinal vasculature to another eye substance like previously described [11] . 
RESULTS
Diabetic rats developed diabetes after 2wk. Ang-2 serum were significantly elevated in all diabetic rats groups compared with normoglycemic Group (P<0.05) (Figure 1 ). To assess the correlation between pericyte migration with increasing of Ang-2, we counted the number of pericyte and endothelial ratio from retinal digest preparation, and compared the number of pericyte migration with total number of pericyte on each groups. From linear regression we found correlation between Ang-2 and the number of pericyte migration ( Figure 2 ). The type of pericyte can be seen on Figure 3 . The differential between normal and diabetic rat retinal vasculature has already seen after 5wk suffer from diabetes ( Figure 4A, 4B) . From each groups we found that the ratio of pericyte: endothelial decrease in positive control group (1:2.4) compared with negative control group (1:1.2). There was differential pericyte:endothelial ratio on groups with Pericyte migration mechanism on diabetic rats . From all diabetic rats groups the most pericyte migration found on Tie-2 inhibitor groups (0.14) (Group 3), and the least pericyte migration found on ERK1/2 inhibitor groups (0.025) (Group 4). The mechanism of pericyte migration can be seen by evaluating the phosphorylation of Tie-2, ERK1/2 and Akt/PKB of the pericyte on each group using confocal microscope. In Figure 5 we can see there is phosphorylation of Tie-2, ERK1/2, and Akt/PKB on the negative control pericyte. The result of quatitative measurement of pericyte phosphorylation of each group shows that effect of Tie-2 inhibitor decreasing activity of Tie-2 phosphorylation, and affect downstream signaling pathway, ERK1/2 and Akt/PKB. ERK1/2 inhibitor decrease phosphorylation on Tie-2 receptor and affect Akt/PKB. But inhibition of Akt/PKB shows that the phosphorylation of Tie-2 is relatively the same compared to positive control group, and the phosphorylation of ERK1/2 were slightly decreased ( Figure 6 ). The confocal microscope image of phosphorylation of Tie-2, ERK1/2, and Akt/PKB on the pericyte in negative control group shown on Figure 5 , and the phosphorylation in positive control group and inhibitor groups can be seen in Figure 7 . DISCUSSION Pericyte have been shown to have an important role in retinal vascular stabilization. The normal ratio of pericyte and endothelial covered retinal microvascular is 41%-50% (1:1). It is because the retinal blood flow have the highest metabolism of the body, so retinal tissue needs the tight vascular. The more pericyte covers vascular, the higher function as a barrier. As an endothelial barrier, the loss of pericyte may lead to alteration of endothelial behavior, and change the vascular permeability [1] [2] [3] [4] . Pericyte loss is the earliest histological change and the characteristic of diabetic retina. Previous study showed that Ang-2 will increase on hyperglycemic condition. This study proves that on all diabetic rats groups, there were significant increases of Ang-2 (P<0.05) compared to normoglycemic rats (1.66 ng/mL). According to previous study, hyperglycemia induce ROS overproduction from mitochondria, than produce modified gene transcription, including transcription of Ang-2 [12] [13] . According to Yao et al [14] the increasing of Ang-2 caused by methylglyoxal modification, and subsequently decreasing bonding to glucose-responsive GC box at Ang-2 promoter, than increasing Ang-2 transcription. Angopoietin produced by Weibel-Palade bodies of endothelial has roles for vessel destabilization if there were specific stimuli. It produces on many condition like cancer, chronic disease, metabolic disease, and sepsis [15] [16] . The increasing Ang-2 level cause the persistent disruption of cross-talk between pericyte and endothelial, then the pericyte is loss and retinal vessel destabilized [6] . At hyperglycemic condition, it makes the first characteristic of diabetic retinopathy.
Recent study have showed that Ang-2 induce pericyte loss through migration process, but the mechanism of pericyte Tie-2, ERK1/2, and Akt/PKB phosphorylation on the pericyte Group 1 was normoclycemic rat; Group 2 was diabetic rat injected with DMSO; Group 3 injected with Tie-2 inhibitor; Group 4 injected with ERK1/2 inhibitor, and Group 5 was injected with Akt/ PKB inhibitor. The Tie-2 phosphorylation was decrease on group with Tie-2 inhibitor and ERK1/2 inhibitor; There were decreasing of ERK1/2 phosphorylation on group injected with Tie-2, ERK1/2, and Akt/PKB inhibitor; Decreasing of Akt/PKB phosphorylation shown on three group injected with Tie-2, ERK1/2, and Akt/PKB inhibitor. Quantitative measurement using confocal microscope (au).
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Int J Ophthalmol, Vol. 11, No. 3, Mar.18, 2018 www.ijo.cn Tel:8629-82245172 8629-82210956 Email:ijopress@163.com migration in hyperglycemic state is unclear [7] . Angiopoietin regulates two pathways that mediated cellular motility through its receptor, Tie-2, with activate PI3K and through MAPK pathways. Many study investigate the mechanism of migration pathway through those major signalling pathway but the result still controversial [17] [18] [19] [20] . The role of Ang-2 in Tie-2 phosphorylation is complicated, depend on the stimuli and the cells. The exact role of Ang-2 induced Tie-2 phosphorylation in pericyte and the mechanism of pericyte migration due to hyperglicemia still unknown. In this study we try to explain the mechanism of pericyte migration, through inhibition of migration pathway. On the diabetic rat models group received Tie-2 inhibitor intravitreal, the pericyte loss and migration still happened. Although Ang-2 has been postulated to naturally bind to the Tie-2 receptor in the pericyte as the Ang-Tie system, but theoretically Ang-2 can directly bind integrin, FAK, and subsequently affect downstream signaling pathway, like ERK1/2 and Akt/PKB [17] [18] [21] [22] . According to Park et al [22] there were no Tie-2 receptor in human pericyte. This statement is conflicting with previous study [7, [22] [23] , and with the result on this study. Even though the pericyte loss cannot be stopped maximally, but the decreasing of ERK1/2 and Akt/PKB phosphorylation sugest that inhibition of Tie-2 phosphorylation still have a role for pericyte migration pathway (Figure 8 ). It described from the decreasing of pericyte loss which is better at the hypergliclemic rat injected with Tie-2 inhibitor intravitreal (1:1.8) than those in positive control group (1:2.4). Inhibition with ERK1/2 inhibitor decrease activity of all migration pathway examined in this study. We assumed there were feedback mechanism that makes the upstream pathway (Tie-2) decreased than influences the decreasing of Akt/PKB phosphorylation. Other possibilities shows there is intracellular crosstalk between ERK1/2 and Akt/PKB without involvement of Tie-2 receptor, so the phosphorylation of Akt/PKB decresing with ERK1/2 inhibitor intravitreal. The results showed that the pericyte: endothelial ratio of groups injected with ERK1/2 inhibitor (1:1.7) is the best compared to another diabetic groups in this study.
On the diabetic rat model received Akt/PKB inhibitor intravitreal, we found a dramatically decrease of Akt/PKB phosphorylation, but the changes of Tie-2 and ERK1/2 phosphorylation were minimal. We assume Akt/PKB pathway involed in pericyte migration based on the decreasing of its phosphorylation after administered with Akt/PKB inhibitor, and the ratio of pericyte endothel is better than positive control group (1:1.8 vs 1:2.4). There is supposition that pericyte migration caused by lack of nutritions and environment stress at vascular site, so the pericyte migrate to perivascular. Although pericyte does not contact to blood flow directly, but hypoxia due to hemoreological changes of diabetes makes environmental stress that leading to pericyte migration. Deformity changes and erythrocyte aggregation (rolleaux formation) due to dibetes has a role of increasing blood viscosity than lead to hemoreological changes [24] [25] [26] . According to previous study pericyte apoptosis have been detected after 6mo of experimental diabetes, but our study shows that pericyte loss already detectable after 5wk [7] . We still do not know whether the lost of pericyte happened due to migration only or there was apoptotic process accompany the migration process. Dramatically decreasing Akt/PKB phosphorylation indicate that it is possible that apoptotic process has occured, because one of the Akt/PKB functions is for cellular stability. Unfortunately in this study we did not examine the apoptotic parameters and dose dependency for inhibition migration pathway. For further research we can investigate the pericyte migration pathway in dose dependency of inhibitors. The ERK1/2 pathway seems most important pathway for pericyte migration. On diabetic rats, inhibition of ERK1/2 pathway decrease Tie-2 through upstream signalling pathway and decrease activity of Akt/PKB. The number of pericyte migration is the smallest of all diabetic rats groups, and the pericyte: endothelial ratio is closer to normoglycemic rat group. Targeting ERK1/2 pathway can be a novel therapeutic strategy for prevention of diabetic retinopathy.
